Skip to main content

Bolt Biotherapeutics, Inc.

BOLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001641281

In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.

Superinvestors holding BOLT, Q2 2026

See all superinvestors

No superinvestor reported holding BOLT in Q2 2026.